Skip to content

Clinical trials

Phase 3 Parkinson Disease trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 3 Country / region: Canada Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20041
20052
20063
20075
20082
20094
20101
20131
20147
20155
20172
20181
20195
20202
20212
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Terminated8
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie6
Adamas Pharmaceuticals, Inc.4
Solvay Pharmaceuticals4
Impax Laboratories, LLC3
Theravance Biopharma3
University of Rochester3
Acorda Therapeutics2
Biotie Therapies Inc.2
Kyowa Kirin Co., Ltd.2
Newron Pharmaceuticals SPA2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease48
Dyskinesias10
Parkinsonian Disorders9
Brain Diseases3
Central Nervous System Diseases3
Dizziness3
Hypotension3
Movement Disorders3
Nervous System Diseases3
Neurodegenerative Diseases3

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.